Otros idiomas Portage Biotech Inc.

Acciones

PRTG

VGG7185A1286

Mercado cerrado - Nasdaq Otros sitios de cotización 21:58:22 25/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,2208 ^USD	-9,10 %		-21,14 %	-87,87 %

03/06	Wall Street abrirá ligeramente al alza el lunes mientras los inversores esperan los datos manufactureros clave de mayo	MT
03/06	Los inversores esperan los datos manufactureros clave y los futuros de EE.UU. suben en la sesión previa a la comercialización del lunes	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	03/06
Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	03/06
Portage Biotech : Director Resignations - Form 6-K	02/05
EPortage Biotech Inc. Announces Board Changes	01/05
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives-Adenosine clinical development paused	15/04
Portage biotech announces plans to expand its evaluation of strategic alternatives	15/04
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	15/04
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives	12/04
Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives	12/04
Portage biotech completes monetization of intensity therapeutics shares	27/03
Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares	26/03
Portage Biotech : Corporate Presentation - March 2024	07/03
Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update	28/02
Portage Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02
Portage Biotech to Pause Drug Development in PORT-2 iNKT Program, to Cut Workforce	04/01
Portage Biotech to Evaluate Range of Strategic Options	04/01
Portage Biotech Reports Business and Strategic Update	04/01
Portage Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	28/11
Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update	28/11
Portage biotech presents updates on its inkt and adenosine programs at the society for immunotherapy of cancer's 38th annual meeting	07/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Portage Biotech Inc.

Acciones

PRTG

VGG7185A1286

Otros idiomas

Filtros